AGFB Agfa-Gevaert NV

Agfa announces additional measures to adjust the cost base of its traditional film activities to the reality in the market

Agfa announces additional measures to adjust the cost base of its traditional film activities to the reality in the market

December 4, 2025 – 7:45 a.m. CET

Regulated information

Agfa announces additional measures to adjust the cost base of its traditional film activities to the reality in the market

Mortsel, Belgium – December 4, 2025 – 7:45 a.m. CET

Agfa today announced that it plans to implement additional measures to adjust the cost base of its traditional film activities to the accelerated global market decline. These measures are an extension to the plan that was announced in November 2024.

On December 4, the intention to implement these additional measures was presented to the social partners in Belgium at an Extraordinary Works Council meeting.

Over the past year, the decline of the global markets for traditional film products – in particular for medical film – accelerated sharply. In response, Agfa intends to expand the plan that was announced in November 2024. The execution of the original plan has also been accelerated.

The intended additional measures would be executed in 2026 and 2027, and could impact up to 145 employees in Belgium. Agfa intends to avoid as many forced redundancies as possible by using the natural outflow of staff and also by encouraging mutations and re-employment.

“The sharp acceleration of the decline of the global film markets demands strong measures to safeguard the future of our company. We will do our utmost to maintain a constructive social dialogue with the social partners involved and keep the period of uncertainty caused by this announcement as short as possible,” said Pascal Juéry, CEO of the Agfa-Gevaert Group.

(end of message)

About Agfa-Gevaert

The Agfa-Gevaert Group is a leading company in imaging technology, with nearly 160 years of experience. Agfa develops, manufactures and markets analog and digital systems for the healthcare sector, for the printing industry, for the green hydrogen industry and for specific industrial applications. In 2024, the Group realized a turnover of 1,138 million euro.



Contact:

Viviane Dictus

Director Corporate Communications

tel. 4

e-mail:

Attachment



EN
04/12/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agfa-Gevaert NV

 PRESS RELEASE

Agfa announces additional measures to adjust the cost base of its trad...

Agfa announces additional measures to adjust the cost base of its traditional film activities to the reality in the market December 4, 2025 – 7:45 a.m. CET Regulated information Agfa announces additional measures to adjust the cost base of its traditional film activities to the reality in the market Mortsel, Belgium – December 4, 2025 – 7:45 a.m. CET Agfa today announced that it plans to implement additional measures to adjust the cost base of its traditional film activities to the accelerated global market decline. These measures are an extension to the plan that was announced in Novem...

 PRESS RELEASE

Agfa kondigt bijkomende maatregelen aan om de kostenbasis van zijn tra...

Agfa kondigt bijkomende maatregelen aan om de kostenbasis van zijn traditionele filmactiviteiten aan te passen aan de realiteit in de markt 4 december 2025 – 7:45 uur CET Gereglementeerde informatie Agfa kondigt bijkomende maatregelen aan om de kostenbasis van zijn traditionele filmactiviteiten aan te passen aan de realiteit in de markt Mortsel, België – 4 december 2025 – 7u45 Agfa kondigde vandaag aan dat het van plan is bijkomende maatregelen te nemen om de kostenbasis van zijn traditionele filmactiviteiten aan te passen aan de versnelde achteruitgang van de wereldwijde markten. Deze...

Guy Sips ... (+4)
  • Guy Sips
  • Jacob Mekhael
  • Livio Luyten
  • Wim Hoste
Guy Sips
  • Guy Sips

Agfa “Shrinking Business” & “Not-So-Growth Engines”

After three quarters, Agfa's 9M25 “Mature Business” (Radiology and Film DPC) sales dropped -6.4% y/y, driven by the accelerating medical film decline. While its “Growth Engines” (HealthCare IT, Digital Printing Solutions, Green Hydrogen Solutions) are intended to offset this, they also fell -0.9% y/y in the first nine months. We remain cautious (Hold; €1.0 Target Price) until strategic measures deliver and growth engines regain momentum.

Guy Sips
  • Guy Sips

Agfa Decline in medical film was even stronger than expected

Agfa's 3Q25 continued decline in medical film was even stronger than expected (€ 257m 3Q25 sales vs € 275m KBCS & CSS). Although the growth in cloud/SaaS in HealthCare IT all the divisions were below our and CSS forecasts as well on top-line as on REBIT-margins. The increase in Digital Printing & Chemicals was not sufficiently offsetting the impact from the decline in medical film and from cloud transition in HealthCare IT. Despite good cost control, REBIT decreased to -4m, mainly due to the d...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch